Cargando…
Submental Area Treatment with ATX-101: Relationship of Mechanism of Action, Tissue Response, and Efficacy
ATX-101 is an injectable, synthetically derived formulation of deoxycholic acid used for submental fat reduction. METHODS: A narrative review of references relevant to the mechanism of action of ATX-101 and its relationship to efficacy and inflammatory adverse events was conducted. RESULTS: When inj...
Autores principales: | Humphrey, Shannon, Munavalli, Girish S., Yoelin, Steven G., Friedmann, Daniel P., Kavali, Carmen M., Sangha, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106193/ https://www.ncbi.nlm.nih.gov/pubmed/37073386 http://dx.doi.org/10.1097/GOX.0000000000004250 |
Ejemplares similares
-
Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations
por: Teller, Craig F., et al.
Publicado: (2021) -
Novel Expanded Safe Zone for Reduction of Submental Fullness with ATX-101 Injection
por: Shridharani, Sachin M., et al.
Publicado: (2019) -
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials
por: Dayan, Steven H, et al.
Publicado: (2018) -
Evaluating a Topical Adjunctive Post Submental ATX-101 (Deoxycholic Acid) Injection for Improved Recovery: A Single-Center, Double-Blind, Randomized Controlled Pilot Study
por: Shridharani, Sachin M
Publicado: (2021) -
Alopecia after injection of ATX-101 for reduction of submental fat
por: Souyoul, Skylar, et al.
Publicado: (2017)